Диссертация (1140935), страница 32
Текст из файла (страница 32)
Lowik, G. van der Pluijm, H.195Bloys [et al.] // Biochemical and Biophysical Research Communications. – 1989.– Vol. 162, № 3. – P. 1546–1552.206.Lu, K.C. Hyperparathyroidism, glucose tolerance and platelet intracellularfree calcium in chronic renal failure. / K.C. Lu, S.D. Shieh, S.H. Lin [et al.] //Quarterly Journal of Medicine. - 1994. – Vol.
87 (6). – P. 359–365.207.Lu, R. Parathyroid hormone administration improves bone marrowmicroenvironment and partially rescues haematopoietic defects in bmi1-null mice/ R. Lu, Q. Wang, Y. Han, J. Li, X. Yang, D. Miao // PLoS One. – 2014. – Vol. 9(4). - e93864. - doi: 10.1371/journal.pone.0093864208.Lütfioğlu, M. Dietary-induced hyperparathyroidism affects serum andgingival proinflammatory cytokine levels in rats. / M. Lütfioğlu, U. Sakallioğlu,E.E. Sakallioğlu, E.
Diraman, G. Çiftçi, F. Tutkun // Journal of Periodontology. –2010. – Vol. 81, № 1. – P. 150–157.209.Lyritis, G.P. Bone anabolic versus bone anticatabolic treatment ofpostmenopausal osteoporosis. / G.P. Lyritis, T. Georgoulas, C.P. Zafeiris // Ann.NY Acad. Sci.
-2010. – Vol. 1205. – P. 277–283210.Mannstadt, M. Receptors for PTH and PTHrP: their biological importanceand functional properties. / M. Mannstadt, H. Juppner, T.J. Gardella. // AmericanJournal of Physiology. – 1999. – Vol. 277. – P. F665–F675.211.Mansouri, L. Leukocyte proliferation and immune modulator production inpatients with chronic kidney disease. / L. Mansouri, J.M. Paulsson, A.Moshfegh, S.H. Jacobson, J. Lundahl. // PLoS One. – 2013.
- Vol. 8 (8). e73141. - doi: 10.1371/journal.pone.0073141.212.Mahon, M.J. A docking site for G protein βγ subunits on the parathyroidhormone 1 receptor supports signaling through multiple pathways. / M.J. Mahon,T.M. Bonacci, P. Divieti, A.V. Smrcka // Mol. Endocrinol. – 2006. – Vol. 20. – P.136–146.213.Marie, P.J. Role of N-cadherin in bone formation. / P.J. Marie // J. Cell.Physiol. – 2002. – Vol. 190.
– P. 297–305.214.Martin, A. Bone proteins PHEX and DMP1 regulate fibroblastic growth196factor Fgf23 expression in osteocytes through a common pathway involving FGFreceptor (FGFR) signaling. / A. Martin, S. Liu, V. David [et al.] // FASEB J. –2011. – Vol. 25, № 8. P. 2551–2562.215.Massry, S. Dysfunction of polymorphonuclear leukocytes in uremia: role ofparathyroid hormone.
/ S. Massry, M. Smogorzewski. // Kidney Int. Suppl. –2001. – Vol. 78. – P. S195-196.216.Massry, S.G. Impaired agonist-induced calcium signaling in hepatocytesfrom chronic renal failure. / S.G. Massry, M. Klin, Z. Ni, J. Tian, L. Kedes, M.Smogorzewski // Kidney Int. – 1995. – Vol.
48. – P. 1324–1331.217.Matsumori, A. Calcium channel blockers differentially modulate cytokineproduction by peripheral blood mononuclear cells. / A. Matsumori, R. Nishio, Y.Nose. // Circ. J. – 2010. – Vol. 74 (3). – P. 567-571.218.Matsuo, K. Increased proinflammatory cytokine production and decreasedcholesterol efflux due to downregulation of ABCG1 in macrophages exposed toindoxyl sulfate / K. Matsuo, S. Yamamoto, T. Wakamatsu, Y. Takahashi, K.Kawamura, Y.
Kaneko, S. Goto, J.J. Kazama, I. Narita // Toxins (Basel). – 2015.- Vol. 7(8). – P. 3155–3166.219.McCarty, M.F. Secondary hyperparathyroidism promotes the acute phaseresponse—a rationale for supplemental Vitamin D in prevention of vascularevents in the elderly.
/ M.F. McCarty // Medical Hypotheses. – 2005. – Vol. 64,№ 5. – P. 1022–1026.220.McDonald, H.I. Chronic kidney disease as a risk factor for acutecommunity-acquired infections in high-income countries: a systematic review. /H.I. McDonald, S.L. Thomas, D.
Nitsch. // BMJ Open. – 2014. – Vol. 4 (4) –e004100. – doi: 10.1136/bmjopen-2013-004100.221.Meena, A. Sustained signalling by PTH modulates IP3 accumulation andIP3 receptors through cyclic AMP junctions / A. Meena, S.C. Tovey, C.W.Taylor // J. Cell. Sci. – 2015. – Vol. 128 (2). – P. 408–420.222.Melenhorst, W.B. ADAM17 upregulation in human renal disease: A rolein modulating TGF-α availability. / W.B. Melenhorst, L. Visser, A.
Timmer [et197al.] // Am. J. Physiol. Renal. Physiol. – 2009. – Vol. 297. – P. F781–F790.223.Meijers, R.W. T-cell ageing in end-stage renal disease patients: Assessmentand clinical relevance. / R.W. Meijers, M.G. Betjes, C.C. Baan, N.H. Litjens //World J. Nephrol. – 2014. – Vol. 3 (4). – P. 268–276.224.Meuer, S.C.
Selective blockade of the antigen-receptor-mediated pathwayof T cell activation in patients with impaired primary immune responses. / S.C.Meuer, M. Hauer, P. Kurz, K-H. Meyer zum Buschenfelde, H. Kohler // Journalof Clinical Investigation. – 1987. – Vol. 80 (3). – P.
743–749.225.Michaud, J. Role of parathyroid hormone in the downregulation of livercytochrome P450 in chronic renal failure. / J. Michaud, J. Naud, J. Chouinard, F.Désy, F.A. Leblond, K. Desbiens, A. Bonnardeaux, V. Pichette // J. Am. Soc.Nephrol. – 2006. – Vol. 17 (11). – P. 3041-3048.226.Migliore, A. Mixed-treatment comparison of anabolic (teriparatide andPTH 1-84) therapies in women with severe osteoporosis.
/ A. Migliore, S.Broccoli, U. Massafra [et al.] // Curr. Med. Res. Opin. – 2012. – Vol. 28. – P.467–473.227.Mitnick, M.A. Parathyroid hormone induces hepatic production ofbioactive interleukin-6 and its soluble receptor. / M.A. Mitnick, A. Grey, U.Masiukiewicz [et al.] // American Journal of Physiology: Endocrinology andMetabolism. – 2001.
– Vol. 280, № 3. - P. E405–E412.228.Morange, P.E. Polymorphisms of the tumor necrosis factor-alpha (TNF)and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation tocardiovascular mortality: the AtheroGene study. / P.E. Morange, D.A. Tregouet,T. Godefroy [et al.] // J. Mol. Med. – 2008. – Vol. 86.
– P. 1153–1161.229.Mori, G. The Interplay between the bone and the immune system. /G. Mori, P. D'Amelio, R. Faccio, G. Brunetti. // Clin. Dev. Immunol. – 2013. –Vol. 2013. – P. 720504. doi: 10.1155/2013/720504. Epub 2013 Jul 14.230.Nakayama, M. Polymorphonuclear leukocyte injury by methylglyoxal andhydrogen peroxide: A possible pathological role for enhanced oxidative stress inchronic kidney disease / M. Nakayama, K. Nakayama, W.J. Zhu [et al.] //198Nephrol.
Dial. Transplant. – 2008. – Vol. 23. – Р. 3096-3102.231.Naud, J. Current understanding of drug disposition in kidney disease. / J.Naud, T.D. Nolin, F.A. Leblond [et al.]. – J. Clin. Pharmacol. – 2012. –Vol. 52. –P. 10S–22S.232.Naveh-Many, T. Protein-RNA interactions in the regulation of PTH geneexpression by calcium and phosphate. / T. Naveh-Many, A.
Sela-Brown, J.Silver // Nephrol. Dial. Transplant. – 1999. – Vol. 14. – P. 811–813.233.Nehra, S. Amlodipine protects rat ventricular cardiomyoblast H9c2 Fromhypoxia-induced apoptosis and restores oxidative balance by Akt-1-dependentmanner. / S. Nehra, V. Bhardwaj, D. Saraswat // J.
Cardiovasc. Pharmacol. –2014. – Vol. 64(4). – P. :375-384. doi: 10.1097/FJC.0000000000000130.234.Nikodimopoulou, M. Secondary hyperparathyroidism and target organs inchronic kidney disease / M. Nikodimopoulou, S. Liakos // Hippokratia. – 2011. –Vol. 15 (Suppl 1). – P. 33–38.235.Nishikawa, N. Expression of parathyroid hormone/parathyroid hormone-related peptide receptor 1 in normal and diseased bladder detrusor muscles: aclinico-pathological study. / N. Nishikawa, R. Yago, Y.
Yamazaki, H. Negoro, M. Suzuki, M. Imamura, Y. Toda, K. Tanabe, O. Ogawa, A. Kanematsu // BMCUrol. – 2015. – Vol. 15 (1). – P. 2. doi: 10.1186/1471-2490-15-2.236.Obri, A. HDAC4 integrates PTH and sympathetic signaling in osteoblasts. /A. Obri, M.P. Makinistoglu, H. Zhang, G. Karsenty // J. Cell. Biol. – 2014. – Vol.205 (6). – P. 771-780.237.Оgard, C.G. Increased plasma N-terminal pro-B-type natriuretic peptideand markers of inflammation related to atherosclerosis in patients with primaryhyperparathyroidism.
/ C.G. Оgard, M.D. Engelmann, C. Kistorp, S.L. Nielsen,H. Vestergaard // Clinical Endocrinology. – 2005. – Vol. 63, №5. – P. 493–498.238.Okada, M. Tertiary hyperparathyroidism resistant to cinacalcet treatment. /M. Okada, Y. Tominaga, K. Izumi [et al.] // Ther. Apher. Dial. – 2011. – Vol. 15,Suppl. 1. – P. 33–37.239.Okano, K. Parathyroid hormone (PTH)/PTH-related protein (PTHrP)199receptor and its messenger ribonucleic acid in rat aortic vascular smooth musclecells and UMR osteoblast-like cells: cell-specific regulation by angiotensin-II andPTHrP.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
